Man Group
HCAT icon

Man Group’s Health Catalyst HCAT Stock Holding History

Man Group’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,247
Closed -$91.4K – 2318
2025
Q2 		$91.4K Sell
24,247
-42,821
-64% -$168K ﹤0.01% 2121
2025
Q1 		$304K Buy
+67,068
New +$355K ﹤0.01% 1930
2024
Q2 		– Sell
-42,534
Closed -$320K – 2115
2024
Q1 		$320K Buy
42,534
+4,516
+12% +$41.2K ﹤0.01% 1920
2023
Q4 		$352K Buy
+38,018
New +$311K ﹤0.01% 1777
2023
Q1 		– Sell
-16,421
Closed -$175K – 2148
2022
Q4 		$175K Sell
16,421
-13,830
-46% -$134K ﹤0.01% 1802
2022
Q3 		$294K Buy
+30,251
New +$401K ﹤0.01% 1671
2022
Q2 		– Sell
-13,240
Closed -$226K – 1442
2022
Q1 		$346K Buy
+13,240
New +$376K ﹤0.01% 1707

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Man Group's HCAT Position: Q3 2025 in Review

Man Group sold out of Health Catalyst (HCAT) in Q3 2025, closing a stake of 24,247 shares — an estimated $91.4K sold.

Man Group first reported a position in HCAT in Q1 2022 and held it in 7 quarters. The position peaked at $352K in Q4 2023. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

  • Man Group reported no remaining Health Catalyst position as of Q3 2025 after selling out during the quarter.
  • Man Group sold 24,247 Health Catalyst shares in Q3 2025, an estimated $91.4K.
  • Man Group first reported a position in Health Catalyst in Q1 2022 and held it in 7 quarters.
  • Man Group's Health Catalyst position peaked at $352K in Q4 2023.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.